Back to companies
Aclaris Therapeutics, Inc.
ACRSUSNASDAQPharmaceuticals & HealthcareAclaris Therapeutics, Inc.
Revenue
$7.8mn
YoY -58.2%
Operating income
-$76.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API